| Financial Year |
March 31 2023 |
| Monetary Funds |
462,546,965.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
694,375,182.49 |
| Advances to Suppliers |
139,578,403.49 |
| Other Receivables |
21,024,403.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
532,506,612.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,576,605.67 |
| Other Current Assets |
4,031,883.03 |
| Total Current Assets |
1,966,017,800.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
11,989,492.41 |
| Long-term Equity Investment |
-- |
| Investment Properties |
23,806,851.56 |
| Fixed Assetes |
1,290,101,715.17 |
| Under-construction Projects |
11,467,297.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
354,665,186.53 |
| R&D expenses |
13,020,691.79 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
132,071.99 |
| Deferred Income Tax Assets |
80,199,342.81 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,785,382,650.22 |
| Total Assets |
3,751,400,450.72 |
| Short-Term Loans |
300,162,541.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
820,965,158.05 |
| Accounts Payable |
965,960,059.87 |
| Accounts Received In Advance |
1,357,906.17 |
| Employee Compensation Payable |
56,449,364.04 |
| Taxes Payable |
67,650,084.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
348,559,619.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
56,843,119.81 |
| Other Current Liabilities |
13,216,449.56 |
| Sub-Total of Current Liabilities |
2,732,829,299.76 |
| Long-term Loans |
19,840,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
15,787,929.16 |
| Special Payable |
-- |
| Estimatied Liabilities |
743,101.56 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
380,084,660.56 |
| Total Liabilities |
3,112,913,960.32 |
| Paid-In Capital(Or Share Stock) |
640,000,000.00 |
| Capital Surplus |
546,579,951.68 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-758,827,248.87 |
| Minority Stockholder's Interest |
210,733,787.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
427,752,702.81 |
| Owner's Equity（Stockholder's Equity） |
638,486,490.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,751,400,450.72 |
